Pragmatic randomized controlled trial to study the efficacy of two experience sampling intervention modules for depression.
ZELF-i is a multi-site trial designed according to the principles of a pragmatic RCT to allow evaluation of the intervention in real-life care facilities. Details are described below according to the SPIRIT guidelines.
Data based on 161 male and female adult patients referred for depressive complaints in the North of the Netherlands.
Researchers are advised to first contact the listed contact person for more information about ZELF-i, such as current research projects, available data, and how to get access to ZELF-i data. In short: to apply for ZELF-i data by external users, a research protocol and analysis plan need to be submitted, which will be reviewed by the PIs. Once the application has been approved, applicants will receive a Data Transfer Agreement (DTA). The DTA describes in detail which data is being acquired and the purposes and terms for using them. The release of data starts off when the DTA has been signed by both parties.
- Personalized medicine
- Experience sampling
- Randomized Controlled trial